487 Results

People

  1. De Angelis
    De Angelis
  2. Abrey
    Abrey
  3. Kelsen
    Kelsen
  4. Lichtman
    Lichtman
  5. Bajorin
    Bajorin
  6. Perales
    Perales
  7. Yahalom
    Yahalom
  8. Saltz
    Saltz
  9. Seidman
    Seidman
  10. Correa
    Correa

Groups

  1. Department of Medicine (257)
  2. Solid Tumor Oncology Division (171)
  3. Hematologic Malignancies, Division of (102)
  4. Center for Hematologic Malignancies (89)
  5. Survivorship Research (72)
  6. Tow Center for Developmental Oncology (TCDO) (51)
  7. Gastrointestinal Oncology Service (50)
  8. Surgery (45)
  9. Genitourinary Oncology Service (42)
  10. Bone Marrow Transplant (38)
  1. "neurotoxicity"
Formats
  1. Journal Article (426)
  2. Review (34)
  3. Editorial (6)
  4. Conference Paper (5)
  5. Book Section (4)
  6. Correspondence (4)
  7. Guidelines (3)
  8. Meeting Abstract (2)
  9. Research Letter (2)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (257)
  2. Solid Tumor Oncology Division (171)
  3. Hematologic Malignancies, Division of (102)
  4. Center for Hematologic Malignancies (89)
  5. Survivorship Research (72)
  6. Tow Center for Developmental Oncology (TCDO) (51)

More Groups

People
  1. Lisa De Angelis (44)
  2. Lauren Abrey (29)
  3. David Kelsen (19)
  4. Stuart Lichtman (18)
  5. Dean Bajorin (17)
  6. Joachim Yahalom (17)

More People

Years
  1. 2025 (25)
  2. 2024 (26)
  3. 2023 (18)
  4. 2022 (10)
  5. 2021 (5)
  6. 2020 (6)

More Years

Publications
  1. Journal of Clinical Oncology (46)
  2. Cancer (19)
  3. Seminars in Oncology (15)
  4. Gynecologic Oncology (13)
  5. Journal of Neuro-Oncology (13)
  6. Blood (11)

More Publications

Publishers
  1. Elsevier Inc. (80)
  2. American Society of Clinical Oncology (47)
  3. Springer (41)
  4. Nature Publishing Group (28)
  5. Wiley Blackwell (27)
  6. Lippincott Williams & Wilkins (26)

More Publishers

Results (487)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dermatologic adverse events associated with chimeric antigen receptor T-cell therapy: A pharmacovigilance analysis of the FDA Reporting System
    Journal Article

    Storgard, R.; Dusza, S.; Shouval, R.; Scordo, M.; Markova, A.
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy
    Review

    Cordas dos Santos, D. M.; Tix, T.; Shouval, R.; Gafter-Gvili, A.; Alberge, J. B.; Cliff, E. R. S.; Theurich, S.; von Bergwelt-Baildon, M.; Ghobrial, I. M.; Subklewe, M.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save
  • Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression
    Journal Article

    Danylesko, I.; Shem-Tov, N.; Yerushalmi, R.; Jacoby, E.; Toren, A.; Shouval, R.; Itzhaki, O.; Avigdor, A.; Shimoni, A.; Nagler, A.
    Current Research in Translational Medicine (2024)

    Fulltext@MSK | Save
  • Plain language summary of the KarMMa-3 study of ide-cel or standard of care regimens in people with relapsed or refractory multiple myeloma
    Editorial

    Rodriguez-Otero, P.; Ailawadhi, S.; Arnulf, B.; Patel, K.; Cavo, M.; Nooka, A. K.; Manier, S.; Callander, N.; Costa, L. J.; Vij, R.; more...
    Future Oncology (2024)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T-cells: A review on current status and future directions for relapsed/refractory multiple myeloma
    Review

    Hamadeh, I. S.; Friend, R.; Mailankody, S.; Atrash, S.
    Frontiers in Oncology (2024)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysis
    Correspondence

    Alsouqi, A.; Ahmed, G.; Wang, J.; Cassanello, G.; Szabo, A.; Rojek, A. E.; Riedell, P. A.; Awan, F.; Samples, L.; Shadman, M.; more...
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR) T-cell therapy use in patients with multiple myeloma and kidney failure on maintenance hemodialysis: A report of 2 cases
    Journal Article

    Pak, W. L. W.; Brumwell, N. A.; Kabel, C. C.; Gutgarts, V.; Jaffer Sathick, I.; Mailankody, S.; Lesokhin, A. M.; Landau, H. J.; Shaikh, A.
    Kidney Medicine (2024)

    Fulltext@MSK | Save
  • Overview of infectious complications among CAR T- cell therapy recipients
    Review

    Arya, S.; Shahid, Z.
    Frontiers in Oncology (2024)

    Fulltext@MSK | Save
  • Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicity
    Journal Article

    Locke, F. L.; Siddiqi, T.; Jacobson, C. A.; Ghobadi, A.; Ahmed, S.; Miklos, D. B.; Perales, M. A.; Munoz, J.; Fingrut, W. B.; Pennisi, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials
    Journal Article

    Nicolò€, E.; Gandini, S.; Giugliano, F.; Uliano, J.; D'Ecclesiis, O.; Morganti, S.; Ferraro, E.; Trapani, D.; Tarantino, P.; Zagami, P.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save